Pharmaceutical Market Europe • December 2024 • 3

COMMENT

The escalating challenges of treating COPD

Our cover story this month features John Forni, Country Medical Director at Sanofi UK & Ireland, and I spoke to John about the escalating challenges of treating chronic obstructive pulmonary disease (COPD) in the UK and how the government, NHS and industry can work together to tackle this pressing issue.
With the recent release of Sanofi’s new report, Breathe Equal: Policy Recommendations to Reduce the Burden of COPD, I asked John how he hopes the report will help to improve current COPD diagnosis rates and care.

John said: “The report places a spotlight on COPD. It is based on insights gathered from expert clinicians throughout the UK as part of a COPD roadshow [that travelled] to Southampton, Manchester, Hull, London, Newcastle and Leicester.

“We were delighted that Asthma + Lung UK attended a number of the sessions to speak about the role of policy change. We heard from over 100 clinicians at these meetings, who shared their different experiences and highlighted the key statistics and important data from their areas, increasing awareness of developing areas of excellence and enabling the clinicians to share best practice.” Find out more on page 16.

Also in this month’s issue, Danny Buckland’s article looks at the need for a human touch in an AI world. As Danny says: “AI is shooting for the moon and the stars but the real benefits come from anchoring it to the human voice.” Read more on page 38.

We’re delighted that PMGroup has just celebrated the 24th annual PMEAs, holding the black tie event at the Sheraton Grand hotel in London. Featuring 17 categories, the event hosted attendees gathering to celebrate excellence in pharmaceutical marketing. Turn to page 30 to see full coverage of the event, including photos of all the excitement from the night!

Our next issue, in January 2025, will look at the role of AI-assisted healthcare for increased patient autonomy. If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com

On behalf of the whole team at PMGroup, I wish all our readers a happy festive season!

Image

Iona Everson
Group Managing Editor

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register

Image

THE TEAM
Editorial:
Group Managing Editor
Iona Everson

Deputy Editor
Emily Kimber


Studio:
Executive Director
Karl Equi

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation

Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim

Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences

Stefan Janssens
President EMEA, Cegedim Dendrite

John Morris
Partner, KPMG

Paul Pay
Chief business development officer, Norgine

Mark Rothera
Chief executive officer, Orchard Therapeutics

Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201

CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

© 2024 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.

The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Image